Catalogo Ricerca UniNA

Catalogo Ricerca UniNA: [354996] Home page macrotipologia

Sfoglia

1 Contributo su Rivista 178034
- 1.1 Articolo in rivista 167313
- 1.2 Recensione in rivista 3304
- 1.3 Scheda bibliografica 654
- 1.4 Nota a sentenza 843
- 1.5 Abstract in rivista 3992
- 1.6 Traduzione in rivista 153
- 1.7 Commento, erratum, replica e simili 690
- 1.8 Articolo in rassegna (review) 1087

2 Contributo in Volume 45831
- 2.1 Contributo in volume (Capitolo o Saggio) 42769
- 2.2 Prefazione/Postfazione 834
- 2.3 Breve introduzione 333
- 2.4 Voce (in dizionario o enciclopedia) 1331
- 2.5 Traduzione in volume 151
- 2.6 Recensione in volume 54
- 2.7 Schede di catalogo, Repertorio o Corpus 360

3 Libro 8146
- 3.1 Monografia o trattato scientifico 7736
- 3.2 Concordanza 2
- 3.3 Indice 12
- 3.4 Bibliografia 26
- 3.5 Edizione Critica Di Testi/Edizione Critica Di Scavo 122
- 3.6 Pubblicazione di fonti inedite 22
- 3.7 Commento scientifico 51
- 3.8 Traduzione di libro 139
- 3.9 Manuale didattico 36

4 Contributo in Atti di Convegno (Proceeding) 55319
- 4.1 Articoli in Atti di convegno 49209
- 4.2 Abstract in Atti di convegno 4990
- 4.3 Poster 1120

5 Altro 5307
- 5.01 Composizione 12
- 5.02 Disegno 57
- 5.03 Design 3
- 5.04 Performance 56
- 5.05 Esposizione 83
- 5.06 Catalogo di Mostra 116
- 5.07 Contributo in Catalogo di Mostra 504
- 5.08 Concorsi di Progettazione 325
- 5.09 Manufatto 2
- 5.10 Prototipo d'arte e relativi progetti 28
- 5.11 Cartografia 175
- 5.12 Banca dati 181
- 5.13 Software 46
- 5.14 Altro ministeriale 3586
- 5.15 Progetto Architettonico 133

6 Brevetti 777
- 6.1 Brevetto 777

7 Curatele 4514
- 7.1 Curatore o Editor di Libri Scientifici 4514

8 Altro non ministeriale 57071

Prodotti recenti

Digitalizzazione, poteri datoriali e qualificazione del rapporto di lavoro

Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study

Background and aims: Homozygous familial hypercholesterolemia (HoFH) is a hereditary lipid metabolism disorder characterized by severe elevation of low-density lipoprotein cholesterol (LDL-C) and heightened risk of premature atherosclerotic cardiovascular disease (ASCVD). Lomitapide, an inhibitor of microsomal triglyceride transfer protein, has shown promise in reducing LDL-C levels, albeit with variable response in real-world settings. Sex-based differences in treatment efficacy and safety r...

New insights into the management of homozygous familial hypercholesterolemia patients treated with lomitapide: a single-center experience

Familial hypercholesterolemia (FH) is a genetic disease, usually with onset during childhood, characterized by elevated blood LDL cholesterol levels and potentially associated with severe cardiovascular complications. Concerning mutated genes in FH, such as LDLR, a small subset of FH patients presents a homozygous genotype, resulting in homozygous FH (HoFH) disease with a generally aggressive phenotype. Besides statins, ezetimibe and PCSK9 inhibitors, lomitapide (an anti-ApoB therapy) was als...

Efficacy and safety of lipid-lowering therapies in combination with or without statin to reduce the cardiovascular risk: A systematic review of randomised controlled trials

Background and aims: Cardiovascular diseases (CVD) pose a significant global health burden. Lowering low-density lipoprotein-cholesterol is the primary therapeutic aim for preventing primary and secondary CVD events. While statins are the standard treatments, their limitations, such as side effects and intolerance in certain patient groups, necessitate exploration of alternative lipid-lowering therapies (LLTs). We systematically reviewed randomised controlled trials (RCTs) evaluating cardiova...

Diagnosis and Screening Strategies for Detection of Familial Hypercholesterolaemia in Children and Adolescents in Italy: A Survey from the LIPIGEN Paediatric Group

Background: Awareness, diagnosis, and treatment of familial hypercholesterolemia (FH) starting from childhood are a cornerstone of cardiovascular disease prevention. The LIPIGEN Paediatric Group, a network of specialised centres for the diagnosis and management of familial genetic dyslipidemia, is an active part of this mission. Materials and Methods: This is the second exploratory survey organised within the LIPIGEN (LIpid transPort disorders Italian GEnetic Network) paediatric centres. A di...

Scopri

Accesso al fulltext

no fulltext288137
open29041
reserved20320
restricted17179
partially open217
embargoed54
mixed41
internalNetwork7